A treatment program for adolescents with phenylketonuria

L. A. Gleason, K. Michals, Reuben Matalon, P. Langenberg, S. Kamath

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

A treatment program for adolescents with phenylketonuria (PKU), incorporating education, goal-setting, self-monitoring, contracts, and rewards, was evaluated by measuring knowledge of PKU, blood phenylalanine concentrations, and health locus of control (LOC) before and after participation in the program. Of the 16 subjects, seven subjects successfully completed the program by achieving behavioral goals. These subjects increased their knowledge of PKU and decreased their blood phenylalanine concentrations, but the nine nonsuccessful subjects did not. There was no significant change in LOC scores for either group. There was a significant relationship between baseline blood phenylalanine levels and success with the program. Therefore, this pilot study demonstrates that adolescents who have already achieved some measure of metabolic control can be expected to be most successful with this program and realize the greatest benefits from it in the form of increased knowledge of PKU and even better metabolic control.

Original languageEnglish (US)
Pages (from-to)331-335
Number of pages5
JournalClinical Pediatrics
Volume31
Issue number6
StatePublished - 1992
Externally publishedYes

Fingerprint

Phenylketonurias
Phenylalanine
Internal-External Control
Therapeutics
Contracts
Reward
Education
Health

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Gleason, L. A., Michals, K., Matalon, R., Langenberg, P., & Kamath, S. (1992). A treatment program for adolescents with phenylketonuria. Clinical Pediatrics, 31(6), 331-335.

A treatment program for adolescents with phenylketonuria. / Gleason, L. A.; Michals, K.; Matalon, Reuben; Langenberg, P.; Kamath, S.

In: Clinical Pediatrics, Vol. 31, No. 6, 1992, p. 331-335.

Research output: Contribution to journalArticle

Gleason, LA, Michals, K, Matalon, R, Langenberg, P & Kamath, S 1992, 'A treatment program for adolescents with phenylketonuria', Clinical Pediatrics, vol. 31, no. 6, pp. 331-335.
Gleason LA, Michals K, Matalon R, Langenberg P, Kamath S. A treatment program for adolescents with phenylketonuria. Clinical Pediatrics. 1992;31(6):331-335.
Gleason, L. A. ; Michals, K. ; Matalon, Reuben ; Langenberg, P. ; Kamath, S. / A treatment program for adolescents with phenylketonuria. In: Clinical Pediatrics. 1992 ; Vol. 31, No. 6. pp. 331-335.
@article{dc9ea629e988404db18bb7185111c80b,
title = "A treatment program for adolescents with phenylketonuria",
abstract = "A treatment program for adolescents with phenylketonuria (PKU), incorporating education, goal-setting, self-monitoring, contracts, and rewards, was evaluated by measuring knowledge of PKU, blood phenylalanine concentrations, and health locus of control (LOC) before and after participation in the program. Of the 16 subjects, seven subjects successfully completed the program by achieving behavioral goals. These subjects increased their knowledge of PKU and decreased their blood phenylalanine concentrations, but the nine nonsuccessful subjects did not. There was no significant change in LOC scores for either group. There was a significant relationship between baseline blood phenylalanine levels and success with the program. Therefore, this pilot study demonstrates that adolescents who have already achieved some measure of metabolic control can be expected to be most successful with this program and realize the greatest benefits from it in the form of increased knowledge of PKU and even better metabolic control.",
author = "Gleason, {L. A.} and K. Michals and Reuben Matalon and P. Langenberg and S. Kamath",
year = "1992",
language = "English (US)",
volume = "31",
pages = "331--335",
journal = "Clinical Pediatrics",
issn = "0009-9228",
publisher = "SAGE Publications Inc.",
number = "6",

}

TY - JOUR

T1 - A treatment program for adolescents with phenylketonuria

AU - Gleason, L. A.

AU - Michals, K.

AU - Matalon, Reuben

AU - Langenberg, P.

AU - Kamath, S.

PY - 1992

Y1 - 1992

N2 - A treatment program for adolescents with phenylketonuria (PKU), incorporating education, goal-setting, self-monitoring, contracts, and rewards, was evaluated by measuring knowledge of PKU, blood phenylalanine concentrations, and health locus of control (LOC) before and after participation in the program. Of the 16 subjects, seven subjects successfully completed the program by achieving behavioral goals. These subjects increased their knowledge of PKU and decreased their blood phenylalanine concentrations, but the nine nonsuccessful subjects did not. There was no significant change in LOC scores for either group. There was a significant relationship between baseline blood phenylalanine levels and success with the program. Therefore, this pilot study demonstrates that adolescents who have already achieved some measure of metabolic control can be expected to be most successful with this program and realize the greatest benefits from it in the form of increased knowledge of PKU and even better metabolic control.

AB - A treatment program for adolescents with phenylketonuria (PKU), incorporating education, goal-setting, self-monitoring, contracts, and rewards, was evaluated by measuring knowledge of PKU, blood phenylalanine concentrations, and health locus of control (LOC) before and after participation in the program. Of the 16 subjects, seven subjects successfully completed the program by achieving behavioral goals. These subjects increased their knowledge of PKU and decreased their blood phenylalanine concentrations, but the nine nonsuccessful subjects did not. There was no significant change in LOC scores for either group. There was a significant relationship between baseline blood phenylalanine levels and success with the program. Therefore, this pilot study demonstrates that adolescents who have already achieved some measure of metabolic control can be expected to be most successful with this program and realize the greatest benefits from it in the form of increased knowledge of PKU and even better metabolic control.

UR - http://www.scopus.com/inward/record.url?scp=0026648407&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026648407&partnerID=8YFLogxK

M3 - Article

C2 - 1628465

AN - SCOPUS:0026648407

VL - 31

SP - 331

EP - 335

JO - Clinical Pediatrics

JF - Clinical Pediatrics

SN - 0009-9228

IS - 6

ER -